Oragenics, Inc. received a Schedule 13G filing showing that Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz together report beneficial ownership of 412,654 shares of Oragenics common stock. This position represents 9.9% of the outstanding common shares as of the filing. The reporting persons state they have shared voting and dispositive power over all 412,654 shares and no sole voting or dispositive power. They also certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Oragenics, but instead are held on a passive basis consistent with a Schedule 13G filing.
Positive
None.
Negative
None.
Insights
Sabby reports a passive 9.9% stake in Oragenics.
The filing shows Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz jointly reporting beneficial ownership of 412,654 Oragenics common shares, or 9.9% of the class. All three report shared, but not sole, power to vote and dispose of these shares, which centralizes influence over this block.
The use of a Schedule 13G and the certification language indicate the position is not intended to change or influence control of Oragenics. This makes the disclosure informational rather than strategic. Actual impact on trading or governance will depend on how this 9.9% holder chooses to vote and manage the position over time.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ORAGENICS INC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
684023609
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
684023609
1
Names of Reporting Persons
SABBY MANAGEMENT, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
412,654.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
412,654.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
412,654.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
CUSIP No.
684023609
1
Names of Reporting Persons
Hal Mintz
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FLORIDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
412,654.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
412,654.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
412,654.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP No.
684023609
1
Names of Reporting Persons
Sabby Volatility Warrant Master Fund, Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
412,654.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
412,654.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
412,654.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
CO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
ORAGENICS INC
(b)
Address of issuer's principal executive offices:
9015 TOWN CENTER PARKWAY, SUITE 143, LAKEWOOD RANCH, FLORIDA, 34202
Address or principal business office or, if none, residence:
Sabby Volatility Warrant Master Fund, Ltd.
c/o Captiva (Cayman) Ltd
Governors Square, Bldg 4, 2nd Floor
23 Lime Tree Bay Avenue
P.O. Box 32315
Grand Cayman KY1-1209
Cayman Islands
Sabby Management, LLC
1011 Links Dr.
Miami Beach, FL 33109
Hal Mintz
c/o Sabby Management, LLC
1011 LInks Dr.
Miami Beach, FL 33109
(c)
Citizenship:
Sabby Volatility Warrant Master Fund, Ltd. - Cayman Islands
Sabby Management, LLC - Delaware, USA
Hal Mintz - USA
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
684023609
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
412,654
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What stake in Oragenics (OGEN) is reported in this Schedule 13G?
The filing reports beneficial ownership of 412,654 shares of Oragenics common stock, representing 9.9% of the outstanding common shares.
Who are the reporting persons in the Oragenics (OGEN) Schedule 13G?
The reporting persons are Sabby Volatility Warrant Master Fund, Ltd., Sabby Management, LLC, and Hal Mintz, each reporting beneficial ownership of the same 412,654 shares.
Do the Oragenics (OGEN) Schedule 13G filers have voting and dispositive power over the shares?
Yes. The filers report 0 shares with sole voting or dispositive power and 412,654 shares with shared voting and shared dispositive power.
Is the 9.9% Oragenics (OGEN) position reported as a passive investment?
Yes. The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Oragenics, consistent with a passive Schedule 13G filing.
What class of securities is covered by this Oragenics (OGEN) Schedule 13G?
The filing covers Oragenics common stock with CUSIP 684023609.
When did the ownership level in this Oragenics (OGEN) Schedule 13G become reportable?
The filing identifies 12/31/2025 as the date of event that required submission of the Schedule 13G.